Akums Drugs and Pharmaceuticals Q1 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
762.05
30.80 (4.21%)
30.80 (4.21%)Volume20.27 K
Updated: Tue 11 Aug, 2026 | 11:15:53
NSE
759.1029.00 (3.97%)
29.00 (3.97%)Volume5.41 L
Updated: Tue 11 Aug, 2026 | 11:01:26
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 931.98 | 1,048.06 | -6.18% | 929.03 | 0.32% |
| Depreciation/ Amortization | 36.92 | 40.12 | -7.69% | 34.06 | 8.38% |
| Operating Income | 92.05 | 109.81 | 48.15% | 90.09 | 2.18% |
| Net Income | 63.48 | 84.61 | -57.00% | 60.17 | 5.49% |
| Other Operating Expenses Total | 137.00 | 146.65 | -1.19% | 122.74 | 11.62% |
| Net Income Before Taxes | 95.65 | 121.22 | 27.30% | 87.48 | 9.34% |
| Total Revenue | 1,024.03 | 1,157.87 | -2.99% | 1,019.11 | 0.48% |
| Selling/ General/ Admin Expenses Total | 176.14 | 199.03 | -4.22% | 176.22 | -0.05% |
| Diluted Normalized EPS | 4.15 | 5.61 | -55.31% | 4.21 | -1.43% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.